2019-11-13T13:39:17-06:00 2018-12-31 910189318 MOSS ADAMS LLP 4747 EXECUTIVE DRIVE SUITE 1300 SAN DIEGO CA 92121 990 2018-01-01 473355381 PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY PARK 4159304386 1 LETTERMAN DRIVE D3500 SAN FRANCISCO CA 94129 JEFFREY A BLUESTONE PRESIDENT & CEO 4159304386 2019-11-12 1 PATRICIA J MAYER P00188643 8586271400 12.129.4.210 2019-11-12 18:13:17 PS P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 3014993178E79CFC6E937B96CD2BA2E742C85339 2018 2020-03-31 21:24:44Z JEFFREY A BLUESTONE 1 LETTERMAN DRIVE D3500 SAN FRANCISCO CA 94129 113439151 0 X WWW.PARKERICI.ORG X 2015 CA THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (PICI) WAS CREATED TO ENCOURAGE ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH AND TO HELP REDUCE OBSTACLES TO COLLABORATION, DISCOVERY AND TRANSLATION OF THESE ADVANCES FOR PATIENTS. THE INSTITUTE ACHIEVES THIS GOAL BY FUNDING A CONSORTIUM OF PREEMINENT ACADEMIC AND MEDICAL RESEARCH INSTITUTIONS WHICH WORK COLLABORATIVELY ON RESEARCH IN THE FIELD OF CANCER IMMUNOTHERAPY. IN ADDITION, PICI FURTHERS ITS CHARITABLE PURPOSES BY EMPLOYING ITS OWN PERSONNEL TO DIRECTLY CONDUCT RESEARCH AND CLINICAL TRIALS. 3 2 80 0 0 97546 63267590 110149251 2635842 3019898 35763 270002 0 0 65939195 113439151 30314269 34959862 0 0 10862639 16056809 0 0 0 13508758 15185495 54685666 66202166 11253529 47236985 17668982 68405361 840350 4490244 16828632 63915117 TO ENABLE REAL COLLABORATION, ACCELERATING THE MOST AMBITIOUS RESEARCH TO DELIVER NEW IMMUNOTHERAPIES ENGINEERED TO SAVE LIVES. 0 0 55201039 34959862 3019898 THE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY ENCOURAGES ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH TO HELP REDUCE OBSTACLES TO COLLABORATION, DISCOVERY AND TRANSLATION OF THESE ADVANCES FOR PATIENTS. THE INSTITUTE FUNDS A CONSORTIUM OF PREEMINENT ACADEMIC AND MEDICAL RESEARCH INSTITUTIONS WHICH WORK COLLABORATIVELY ON RESEARCH AND CLINICAL TRIALS IN THE FIELD OF CANCER IMMUNOLOGY. IN ADDITION, THE INSTITUTE CONDUCTS ITS OWN RESEARCH AND CLINICAL TRIALS AND PROVIDES CONSORTIUM MEMBERS WITH SHARED RESEARCH RESOURCES, SUCH AS SCIENTIFIC EQUIPMENT AND COMSUMABLES, AND A SPECIMEN BIOBANK. 55201039 1 1 0 0 0 0 0 0 0 0 1 0 1 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 1 0 0 0 1 0 0 0 0 0 1 0 0 0 1 21 0 1 80 1 0 0 0 0 0 0 0 0 0 0 0 0 X 3 2 1 0 0 0 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY 4159857311 1 LETTERMAN DRIVE SUITE D3500 SAN FRANCISCO CA 94129 SEAN N PARKER CHAIR OF THE BOARD AND DIR 1.00 X X 0 0 0 MICHAEL POLANSKY VICE PRESIDENT & DIRECTOR 1.00 X X 0 0 0 TOM VAN LOBEN SELS SECRETARY/TREASURER & DIR 1.00 X X 0 0 0 JEFFREY A BLUESTONE PRESIDENT AND CEO 40.00 X 865708 0 51352 SUSAN SCHULTZ VP-BUSINESS OPERATIONS 40.00 X 342513 0 52205 RAMY IBRAHIM VP-CLINICAL RESEARCH & DEV 40.00 X 846563 0 41771 ILAN ZIPKIN VP-BUSINESS DEVELOPMENT 40.00 X 467913 0 43289 NIKESH KOTECHA VP-IMFORMATICS 40.00 X 402652 0 32873 MELINDA GRIFFITH CHIEF LEGAL COUNSEL, VP-ST 40.00 X 349613 0 29812 THERESA LAVALLEE VP-TRANSLATIONAL MEDICIN 40.00 X 405837 0 56330 CHERYL L SELINSKY PHD VP-RESEARCH OPERATIONS 40.00 X 368172 0 17472 4048971 0 325104 48 0 1 0 MASON LIDDIL AND ASSOCIATES 1497 MAIN STREET 238 DUNNEDIN FL 34698 QUALITY ASSURANCE SERVICES 244170 LEIGH FEIGENBAUM 47655 RHYOLITE PLACE POTOMAC FALLS VA 20165 QUALITY ASSURANCE SERVICES 173250 JOYSON KARUKUNNEL 11604 SPRINGRIDGE ROAD POTOMAC MD 20854 QUALITY ASSURANCE SERVICES 172250 FENWICK & WEST LLP PO BOX 742814 LOS ANGELES CA 90074 LEGAL SERVICES 129881 4 110149251 110149251 RESEARCH STUDY SPONSORSHIP 900099 3019898 3019898 3019898 270002 270002 113439151 3019898 0 270002 34959862 34959862 2200112 1428286 771826 11876843 7309746 4567097 257500 213698 43802 1039143 862381 176762 683211 512092 171119 921268 567109 354159 69802 16576 53226 5382312 4223744 1158568 97965 7456 90509 283665 148336 135329 559770 475855 83915 1308972 654486 654486 618070 548796 69274 1631412 1381532 249880 870491 870491 68717 68717 BUSINESS EVALUATIONS 995000 995000 RESEARCH SUPPLIES/TEST 714749 643274 71475 EQUIPMENT/SOFTWARE 683454 640916 42538 RECRUITING 284865 284865 694983 322029 372954 66202166 55201039 11001127 0 3917038 5414164 3701823 6563995 2957 342167 1159990 420000 440474 602805 4823094 1587480 2120083 3235614 6000000 51499999 326617 326617 17668982 68405361 840350 4490244 840350 4490244 X 16502015 63588500 326617 326617 16828632 63915117 17668982 68405361 X 47236985 -150500 X 0 1 X 1 0 X 74021413 39828555 63267590 110149251 287266809 74021413 39828555 63267590 110149251 287266809 128807943 158458866 10489 41843 35762 270002 358096 7045 29812 36857 287661762 5655740 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: SETTLEMENT PROCEEDS - 2015 AMOUNT: $ 7,045. 2016 AMOUNT: $ 29,812. 2017 AMOUNT: $ 0. 2018 AMOUNT: $ 0. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 46383 46383 673048 362591 310457 4103663 1224889 2878774 3235614 IMAGIN-AB (EQUITY INVESTMENT) 2000000 F TMUNITY (EQUITY INVESTMENT) 30000000 F LYELL IMMUNOPHARMA, INC. (EQUITY INVESTMENT) 14499999 F XYPHOS, INC. (EQUITY INVESTMENT) 5000000 F 51499999 X 113441151 2000 2000 113439151 0 113439151 66354666 2000 150500 152500 66202166 0 66202166 PART X, LINE 2: THE ORGANIZATION HAS NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES AS OF DECEMBER 31, 2018 AND 2017. PART XII, LINE 2D - OTHER ADJUSTMENTS: COMPENSATION ADJUSTMENT BOOK/TAX DIFFERENCE 150,500. 1 MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVE BOX 69 NEW YORK NY 10065 912154267 501(C)(3) 6071376 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY STANFORD UNIVERSITY 3145 PORTER DRIVE PALO ALTO CA 94304 941156365 501(C)(3) 3727322 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY UNIVERSITY OF CALIFORNIA LOS ANGELES 10920 WILSHIRE BLVD STE 620 LOS ANGELES CA 90024 956006143 GOVT 3217567 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY WASHINGTON UNIVERSITY 700 ROSEDALE AVENUE CB 1034 SAINT LOUIS MO 63112 430653611 501(C)(3) 175000 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY ICAHN SCHOOL OF MEDICINE ONE GUSTAVE L LEVY PLACE NEW YORK NY 10029 136171197 501(C)(3) 841667 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY REGENTS OF UNIVERSITY OF CALIFORNIA SAN FRANCISCO 333 CALIFORNIA ST 315 SAN FRANCISCO CA 94143 946036493 GOVT 5441294 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY UNIVERSITY OF PENNSYLVANIA 3451 WALNUT STREET PHILADELPHIA PA 19104 231352685 GOVT 5841764 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1400 PRESSLER STREET FCT295223 HOUSTON TX 77030 746001118 GOVT 5169600 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY EMMULATE 27 DRYDOCK AVE BOSTON MA 02210 464857430 500000 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY FHCRC - HUTCHINSON 1100 FAIRVIEW AVE N SEATTLE WA 98109 237156071 501(C)(3) 1000000 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY CALIFORNIA INSTITUTE OF TECHNOLOGY 1200 EAST CALIFORNIA BOULEVARD PASADENA CA 91125 951643307 501(C)(3) 601758 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY CITY OF HOPE 1500 E DUARTE RD DUARTE CA 91010 953435919 501(C)(3) 392202 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVENUE BOSTON MA 02115 042263040 501(C)(3) 966666 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY LA JOLLA INSTITUTE FOR IMMUNOLOGY 9420 ATHENA CIRCLE LA JOLLA CA 92037 330328688 501(C)(3) 62170 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY THE REGENTS UNIVERSITY OF BLACKSTONE PO BOX 748872 LOS ANGELES CA 90074 946036493 GOV 50000 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY TMUNITY 3020 MARKET STREET SUITE 535 PHILADELPHIA PA 19104 475412234 882548 SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY 14 2 PART I, LINE 2: THE ORGANIZATION AWARDS GRANTS SUBJECT TO A MASTER COLLABORATION AGREEMENT AND A SPECIFIC GRANT AGREEMENT APPLICABLE TO EACH INSTITUTION. X 1 1 X X X 0 0 0 0 0 0 0 1 0 JEFFREY A BLUESTONE PRESIDENT AND CEO 865000 0 0 0 708 0 8250 0 43102 0 917060 0 0 0 SUSAN SCHULTZ VP-BUSINESS OPERATIONS 310994 0 31519 0 0 0 8250 0 43955 0 394718 0 0 0 RAMY IBRAHIM VP-CLINICAL RESEARCH & DEV 564300 0 145000 0 137263 0 8250 0 33521 0 888334 0 0 0 ILAN ZIPKIN VP-BUSINESS DEVELOPMENT 456800 0 0 0 11113 0 8250 0 35039 0 511202 0 0 0 NIKESH KOTECHA VP-IMFORMATICS 365363 0 37289 0 0 0 8250 0 24623 0 435525 0 0 0 MELINDA GRIFFITH CHIEF LEGAL COUNSEL, VP-ST 317691 0 31922 0 0 0 8250 0 21562 0 379425 0 0 0 THERESA LAVALLEE VP-TRANSLATIONAL MEDICIN 325200 0 32699 0 47938 0 8250 0 48080 0 462167 0 0 0 CHERYL L SELINSKY PHD VP-RESEARCH OPERATIONS 334300 0 33609 0 263 0 8250 0 9222 0 385644 0 0 0 PART I, LINE 1A ANYONE TRAVELING OVER 3000 MILES CAN FLY BUSINESS CLASS OR FIRST CLASS (IF ONLY 2 LEVELS OF SERVICE ARE OFFERED). VP'S CAN TRAVEL BUSINESS OR FIRST CLASS FOR TRAVEL OVER 2000 MILES. PART I, LINE 3 THE BOARD OF DIRECTORS REVIEWS ANY PROPOSED COMPENSATION, INCLUDING THE SALARY, OF ITS CHIEF EXECUTIVE OFFICER TO ENSURE THAT, IN EACH CASE, SUCH SALARY IS FAIR AND REASONABLE BASED ON COMPARABILITY DATA SHOWING COMPENSATION PAID FOR COMPARABLE SERVICES AT SIMILARLY SITUATED ORGANIZATIONS. PART I, LINE 7 MOST OF THE INSTITUTE'S EMPLOYMENT AGREEMENTS, WHICH ARE NEGOTIATED AT ARMS-LENGTH WITH REFERENCE TO COMPARABILITY DATA, CONTAIN A PROVISION PERMITTING ANNUAL INCENTIVE BONUSES, WHICH ARE CAPPED AT UP TO A FIXED PERCENTAGE. THE CEO HAS NO SUCH INCENTIVE COMPENSATION, HOWEVER, AND IS PAID ON A FIXED SALARY. RAMY IBRAHIM KEY EMPLOYEE RELOCATION X 700000 420000 0 1 1 420000 SEAN N PARKER FOUNDATION COMMON CONTROL LEASE GUARANTEE 0 FORM 990, PART VI, SECTION A, LINE 2 TOM VAN LOBEN SELS AND SEAN PARKER HAVE A BUSINESS RELATIONSHIP. TOM VAN LOBEN SELS AND MICHAEL POLANSKY HAVE A BUSINESS RELATIONSHIP. MICHAEL POLANSKY IS AN EMPLOYEE OF AN ENTITY OWNED BY SEAN PARKER. FORM 990, PART VI, SECTION A, LINE 7A THE CHAIRMAN OF THE BOARD, AS DESIGNATOR, HAS AUTHORITY TO APPOINT MEMBERS OF PICI'S GOVERNING BODY. FORM 990, PART VI, SECTION A, LINE 7B THE CHAIRMAN OF THE BOARD, AS DESIGNATOR, HAS THE AUTHORITY TO REMOVE MEMBERS OF PICI'S GOVERNING BODY, TO CONSENT TO SUCH REMOVAL BY THE BOARD, AND TO CONSENT TO ANY AMENDMENTS TO PICI'S BYLAWS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE AUDIT COMMITTEE. A COMPLETE COPY OF THE FORM 990 AND SUPPORTING SCHEDULES WAS PROVIDED TO THE FULL BOARD FOR REVIEW PRIOR TO BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD AUTHORIZES AND OVERSEES A REVIEW OF THE ADMNISTRATION OF THE CONFLICT OF INTEREST POLICY. THE REVIEW CONSIDERS THE LEVEL OF COMPLIANCE WITH THE POLICY, THE CONTINUING SUITABILITY OF THE POLICY, AND WHETHER THE POLICY SHOULD BE MODIFIED AND IMPROVED. IF A TRANSACTION ARISES WHERE THERE IS A CONFLICT OF INTEREST, THE PERSON WITH SUCH CONFLICT IS NOT ALLOWED TO VOTE ON THE TRANSACTION NOR BE PRESENT FOR SUCH VOTE. FORM 990, PART VI, SECTION B, LINE 15 FORM 990, PART VI, SECTION B, LINE 15A - AS STATED AT SCHEDULE J, PART I, LINE 3, THE BOARD OF DIRECTORS APPROVED THE SALARY OF THE ORGANIZATION'S CHIEF EXECUTIVE OFFICER ONLY AFTER HAVING CONFIRMED IT IS FAIR AND REASONABLE BASED ON COMPARABILITY DATA SHOWING COMPENSATION PAID FOR COMPARABLE SERVICES AT SIMILARLY SITUATED ORGANIZATIONS. THESE PROCEDURES WERE FOLLOWED WHEN THE CHIEF EXECUTIVE OFFICER'S SALARY WAS APPROVED BY THE BOARD OF DIRECTORS, WHICH DOES NOT INCLUDE THE CHIEF EXECUTIVE OFFICER, ON OCTOBER 30, 2017. SPECIFICALLY, THE BOARD OF DIRECTORS RELIED ON A COMPENSATION SURVEY AND FORM 990S OF SIMILAR ORGANIZATIONS. ANY FUTURE CHANGES TO THE COMPENSATION (INCLUDING ANY BONUSES PAID) OF THE CHIEF EXECUTIVE OFFICER WILL ONLY BE APPROVED BY THE BOARD OF DIRECTORS AFTER FOLLOWING THE PROCEDURES DESCRIBED ABOVE. FORM 990, PART VI, SECTION B, LINE 15B - IN GENERAL, PICI WORKED WITH A RECRUITER AND, AS PART OF THAT PROCESS, ROUTINELY COMPARED THE PROPOSED SALARY WITH SALARIES PAID BY OTHER ORGANIZATIONS FOR SIMILAR POSITIONS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATIONS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AS REQUIRED BY LAW. FORM 990, PART XI, LINE 9: COMPENSATION ADJUSTMENT BOOK/TAX DIFFERENCE -150,500. SEAN N PARKER FOUNDATION 314 LYTTON AVENUE SUITE 200 PALO ALTO CA 94301 274389819 SUPPORTS NONPROFIT ORGANIZATIONS CA 501(C)(3) PF N/A 0 ECONOMIC INNOVATION GROUP INC 616 H STREET NW SUITE 550 WASHINGTON DC 20001 462450336 PUBLIC INTEREST ADVOCACY DC 501(C)(4) N/A N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0